Current and future therapies for type 1 diabetes | SpringerLink
Golimumab and Beta-Cell Function in Youth with New-Onset Type 1 Diabetes » Diabetes Institute » College of Medicine » University of Florida
Golimumab May Reduce Insulin Use in Newly Diagnosed Type 1 Diabetes - Endocrinology Advisor
Golimumab preserves beta cell function and reduces insulin use and hypoglycaemia in youth with recently diagnosed type 1 diabetes: the phase 2 T1GER study - Media Centre | EASD
JPM | Free Full-Text | Personalized Immunotherapies for Type 1 Diabetes: Who, What, When, and How?
Golimumab for Type 1 Diabetes - DSM
Golimumab in Youth with New-Onset Type 1 Diabetes | NEJM
TNF--Blocker rettet Betazellen | PZ – Pharmazeutische Zeitung
Golimumab and Beta-Cell Function in Youth with New-Onset Type 1 Diabetes | NEJM
Il mio diabete #ADA Golimumab preserves beta-cell function in children and young adults with Type 1 diabetes
New Frontiers in the Treatment of Type 1 Diabetes - ScienceDirect
Golimumab Overview - Creative Biolabs
IJMS | Free Full-Text | Therapeutic Advances in Diabetes, Autoimmune, and Neurological Diseases
Typ-1-Diabetes: Rheumamittel Golimumab kann endogene Insulinproduktion...
New Frontiers in the Treatment of Type 1 Diabetes - ScienceDirect
Golimumab and Beta-Cell Function in Youth with New-Onset Type 1 Diabetes | NEJM
Golimumab may preserve beta-cell function in Type 1 diabetes: Study
Type 1 Diabetes Research Advances
Golimumab preserves beta-cell function in children and young adults with Type 1 diabetes
Antikörper bremst Typ-1-Diabetes
Golimumab improves insulin production and blood sugar control in T1D: NEJM
Neues in der Diabetestherapie | DGE Blog
Golimumab May Help Preserve Beta-Cell Function Related to Type 1 Diabetes - Diabetes Research Connection
Golimumab and Beta-Cell Function in Youth with New-Onset Type 1 Diabetes | NEJM
Golimumab and Beta-Cell Function in Youth with New-Onset Type 1 Diabetes - Metabolic Health Digest
Golimumab Use in Type 1 Diabetes
